Home/Filings/4/0000950170-24-083397
4//SEC Filing

Nichols William Garrett 4

Accession 0000950170-24-083397

CIK 0001841387other

Filed

Jul 14, 8:00 PM ET

Accepted

Jul 15, 8:32 AM ET

Size

5.2 KB

Accession

0000950170-24-083397

Insider Transaction Report

Form 4
Period: 2024-07-11
Nichols Garrett
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2024-07-11$5.97/sh9,769$58,354125,357 total
Footnotes (1)
  • [F1]The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Documents

1 file

Issuer

Candel Therapeutics, Inc.

CIK 0001841387

Entity typeother

Related Parties

1
  • filerCIK 0001618364

Filing Metadata

Form type
4
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 8:32 AM ET
Size
5.2 KB